| 注册
首页|期刊导航|中国现代医学杂志|激素联合免疫抑制剂对紫癜性肾炎患儿血清白介素16和18水平的影响

激素联合免疫抑制剂对紫癜性肾炎患儿血清白介素16和18水平的影响

何盾 吴芳兰 陈立华 杨曼琼

中国现代医学杂志2017,Vol.27Issue(8):47-50,4.
中国现代医学杂志2017,Vol.27Issue(8):47-50,4.DOI:10.3969/j.issn.1005-8982.2017.08.010

激素联合免疫抑制剂对紫癜性肾炎患儿血清白介素16和18水平的影响

Research on effect of corticosteroid combined with immunosuppressor on children with Henoch-Schonlein purpura nephritis

何盾 1吴芳兰 2陈立华 2杨曼琼3

作者信息

  • 1. 湖南省常德市第一人民医院 皮肤科,湖南 常德 415003
  • 2. 湖南省长沙市第一医院 检验科,湖南 长沙 410005
  • 3. 湖南省人民医院 儿科,湖南 长沙 410005
  • 折叠

摘要

Abstract

Objective To study the effect of corticosteroid combined with immunosuppressor on children with Henoch-Schonlein purpura nephritis (HSPN). Methods A total of 60 patients with HSPN were collected and divide into group A (corticosteroid combined with immunosuppressor) and group B (conventional treatment) according to condition of patients. Serum levels of IL-16 and IL-18 of all patients were detected by ELISA. Results The serum level of IL-16 and IL-18 in group A was higher than those in group B ( <0.05). After treated by corticosteroid combined with immunosuppressor, the serum levels of IL-16 and IL-18 were sig-nificantly lower than those before treatment among group A. Conclusions IL-16 and IL-18 may be involved in the development of HSPN. Corticosteroid combined with immunosuppressor may play a therapeutic role through suppressing IL-16 and IL-18.

关键词

紫癜性肾炎/皮质类固醇激素/免疫抑制剂/IL-16/IL-18

Key words

Henoch-Schonlein purpura nephritis (HSPN)/corticosteroid/immunosuppressor/IL-16/IL-18

分类

医药卫生

引用本文复制引用

何盾,吴芳兰,陈立华,杨曼琼..激素联合免疫抑制剂对紫癜性肾炎患儿血清白介素16和18水平的影响[J].中国现代医学杂志,2017,27(8):47-50,4.

中国现代医学杂志

OACSTPCD

1005-8982

访问量0
|
下载量0
段落导航相关论文